Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINE-MECH: Finerenone for Ventricular Remodeling
NCT07270367Phase 3Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finerenone in heart failure (HF), left ventricular hypertrophy (LVH). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
heart failure (HF)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT07270367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07270367.